Gene: GRIP2
Official Full Name: glutamate receptor interacting protein 2provided by HGNC
Gene Summary: Predicted to enable glutamate receptor binding activity. Predicted to be involved in several processes, including neurotransmitter receptor transport, endosome to postsynaptic membrane; positive regulation of AMPA glutamate receptor clustering; and positive regulation of excitatory postsynaptic potential. Predicted to act upstream of or within Notch signaling pathway; artery smooth muscle contraction; and positive regulation of blood pressure. Predicted to be located in dendritic shaft. Predicted to be active in glutamatergic synapse and postsynaptic density, intracellular component. [provided by Alliance of Genome Resources, Apr 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA06834 | GRIP2 Knockout cell line (AC16) | Human | GRIP2 | 1:3-1:4 | negative | Online Inquiry |
| KOA22278 | GRIP2 Knockout cell line (BEAS-2B) | Human | GRIP2 | 1:3~1:4 | negative | Online Inquiry |
| KOA37724 | GRIP2 Knockout cell line (U-2932) | Human | GRIP2 | 1:2-1:4 | negative | Online Inquiry |
| KOA53125 | GRIP2 Knockout cell line (TPC-1) | Human | GRIP2 | 1:5-1:8 | negative | Online Inquiry |
| KOA68532 | GRIP2 Knockout cell line (NCM460) | Human | GRIP2 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.